bioMérieux Partners in Ambitious Initiative to Promote the Value of Innovative Diagnostic Tests in Battling Antibiotic Resistance

  10 April 2019

The University of Antwerp has announced the creation of an Innovative Medicines Initiative (IMI) called VALUE-Dx, in partnership with bioMérieux and Wellcome Trust. According to the University of Antwerp, “The purpose of VALUE-Dx is to transform medical practice to achieve more personalized, evidence-based antibiotic prescription and use in community care settings through the widespread use of clinical and cost-effective innovative diagnostic strategies.”

Further reading: bioMerieux Connection
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!